Neuraxis Inc (NRXS) Stock Price, Quote & News

Company Profile

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8 years of age with functional abdominal pain associated with irritable bowel syndrome (IBS), functional dyspepsia (FD) and associated FD nausea symptoms. The company also offers rectal expulsion device, a...

Industry: Biotechnology

Sector: Healthcare

Phone: 812 689 0791

Website: neuraxis.com

Address:

11611 North Meridian St, Suite 330, Carmel, United States

iAccess_Alpha Sep. 16 at 2:54 PM

$NRXS presentation replay is now available. Access the replay: https://www.webcaster5.com/Webcast/Page/3171/54417 #microcap #smallcap #investing

0 · Reply

MingChoo Sep. 16 at 2:52 PM

Thank you @ApolloAlerts. One of the best small-cap traders🔥 Made $20K today off his call. Give him a follow💯 Watching; $NAMI & $NRXS

0 · Reply

DylanGFM Sep. 16 at 2:48 PM

Check out medicine Nova $MNOV strong follow through on the daily $NRXS $MEDS

0 · Reply

Finnish_boy Sep. 16 at 2:22 PM

$NRXS This is how you play tiny float names.. lets go!💥🤑

0 · Reply

Finnish_boy Sep. 16 at 2:22 PM

$NRXS Two posts in a hour

0 · Reply

DylanGFM Sep. 16 at 2:20 PM

$NRXS Right. I meant as far as from this exact day on I wouldn't want to buy and hold from here, prob wait till it gets a bit lower for the next long term move iup

1 · Reply

CBAZZ03 Sep. 16 at 1:54 PM

$NRXS This will most definetly be a solid long term stock, think about public reaction once this company hits profitability

0 · Reply

DylanGFM Sep. 16 at 1:51 PM

$NRXS not sure about more long-term buy and hold capability right now but it's at least having a start in intraday gains so far could have a decent scalp or two in it. Who knows, the market being this strong we could see a real nice move

0 · Reply

Finnish_boy Sep. 16 at 1:51 PM

$NRXS Cant buy this. Some issues with my broker😂it is what it is. Oh boy. And Cunha started pumping it.

1 · Reply

Stock_Catcher Sep. 16 at 1:49 PM

$NRXS new high

0 · Reply

NeurAxis to Participate in the Lytham Partners Fall 2026 Investor Conference

Sep 15, 2026, 9:00 AM EDT - 1 day ago

NeurAxis Transcript: IAccess Alpha Virtual Best Ideas Fall Investment Conference 2026

Aug 11, 2026, 9:00 AM EDT - 5 weeks ago

NeurAxis Earnings Call Transcript: Q2 2026

Aug 11, 2026, 9:00 AM EDT - 5 weeks ago

NeurAxis Quarterly report: Q2 2026

Aug 11, 2026, 9:00 AM EDT - 5 weeks ago

NeurAxis Earnings release: Q2 2026

Aug 4, 2026, 7:00 AM EDT - 6 weeks ago

NeurAxis Expands Payer Coverage with New Policies

Jul 30, 2026, 8:00 AM EDT - 6 weeks ago

NeurAxis Registration statement: Registration filing

Jul 28, 2026, 7:00 AM EDT - 7 weeks ago

NeurAxis to Host Second Quarter 2026 Results and Business Update Call on Tuesday, August 11, 2026

2026-07-23T20:45:13.000Z - 7 weeks ago

Neuraxis files to sell 1.92M shares of common stock for holders

Jul 23, 2026, 8:00 AM EDT - 7 weeks ago

NeurAxis Registration statement: Registration filing

May 28, 2026, 11:15 AM EDT - 3 months ago

NeurAxis Transcript: Lytham Partners Spring 2026 Investor Conference

May 27, 2026, 7:00 AM EDT - 3 months ago

NeurAxis Slides: Investor presentation

May 12, 2026, 9:00 AM EDT - 4 months ago

NeurAxis Earnings Call Transcript: Q1 2026

May 12, 2026, 9:00 AM EDT - 4 months ago

NeurAxis Quarterly report: Q1 2026

May 12, 2026, 9:00 AM EDT - 4 months ago

NeurAxis Earnings release: Q1 2026

May 12, 2026, 7:05 AM EDT - 4 months ago

NeurAxis Reports Record First Quarter 2026 Financial Results Driven by 80% Year Over Year Revenue Growth

May 5, 2026, 7:00 AM EDT - 4 months ago

NeurAxis to Host First Quarter 2026 Results and Business Update Call on Tuesday, May 12, 2026

Apr 28, 2026, 8:00 AM EDT - 4 months ago

NeurAxis Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 4 months ago

NeurAxis Proxy statement: Proxy filing

Apr 22, 2026, 7:00 AM EDT - 4 months ago

NeurAxis Expands Payer Coverage with Four New Medical Policies

Apr 10, 2026, 7:00 AM EDT - 5 months ago

NeurAxis, Inc. Announces Preferred Stock Dividend

2026-03-20T12:56:08.000Z - 6 months ago

Neuraxis price target raised to $13 from $8 at Craig-Hallum

Mar 19, 2026, 9:00 AM EDT - 6 months ago

NeurAxis Earnings Call Transcript: Q4 2025

Mar 19, 2026, 9:00 AM EDT - 6 months ago

NeurAxis Earnings release: Q4 2025

Mar 19, 2026, 9:00 AM EDT - 6 months ago

NeurAxis Annual report: Q4 2025

2026-03-19T11:25:31.000Z - 6 months ago

Neuraxis reports Q4 revenue $968K vs. $761K last year

Mar 19, 2026, 7:05 AM EDT - 6 months ago

NeurAxis Reports Strong Fourth Quarter and Full Year 2025 Financial Results

Jan 30, 2026, 7:00 AM EST - 7 months ago

NeurAxis Slides: Corporate presentation

Jan 15, 2026, 9:30 AM EST - 8 months ago

NeurAxis Transcript: 2nd Annual Lytham Partners Healthcare Investor Summit

2026-01-08T13:38:18.000Z - 8 months ago

Neuraxis announces Category I CPT code for PENFS now in effect

2026-01-05T16:05:09.000Z - 8 months ago

Neuraxis management to meet virtually with Craig-Hallum

2025-12-22T15:25:50.000Z - 8 months ago

Neuraxis management to meet virtually with Craig-Hallum

2025-12-22T14:30:21.000Z - 8 months ago

Neuraxis price target raised to $8 from $7 at Craig-Hallum

2025-12-19T13:15:39.000Z - 9 months ago

Neuraxis achieves medical coverage policy milestone for PENFS

2025-12-01T12:20:49.000Z - 9 months ago

Neuraxis secures VA Federal Supply Schedule contract

2025-11-12T13:31:25.000Z - 10 months ago

Neuraxis announces new medical policy coverage in Michigan

Nov 11, 2025, 9:00 AM EST - 10 months ago

NeurAxis Earnings Call Transcript: Q3 2025

Nov 11, 2025, 9:00 AM EST - 10 months ago

NeurAxis Earnings release: Q3 2025

Nov 11, 2025, 9:00 AM EST - 10 months ago

NeurAxis Quarterly report: Q3 2025

2025-11-11T12:06:10.000Z - 10 months ago

Neuraxis reports Q3 revenue $811k vs $667k last year

Nov 11, 2025, 7:00 AM EST - 10 months ago

NeurAxis Reports Strong Third Quarter 2025 Financial Results Driven by a 22% Growth in Revenues

2025-10-24T12:11:28.000Z - 10 months ago

Neuraxis received FDA 510k clearance for PENFS technology

Sep 30, 2025, 11:00 AM EDT - 11 months ago

NeurAxis Transcript: Lytham Partners Fall 2025 Investor Conference

Aug 12, 2025, 9:00 AM EDT - 1 year ago

NeurAxis Earnings Call Transcript: Q2 2025

Aug 12, 2025, 9:00 AM EDT - 1 year ago

NeurAxis Earnings release: Q2 2025

Aug 12, 2025, 9:00 AM EDT - 1 year ago

NeurAxis Quarterly report: Q2 2025

Aug 12, 2025, 9:00 AM EDT - 1 year ago

NeurAxis Slides: Q2 2025

2025-08-12T11:06:07.000Z - 1 year ago

Neuraxis reports Q2 EPS (22c) vs. (42c) last year

2025-06-19T20:45:06.000Z - 1 year ago

Neuraxis management to meet with Craig-Hallum

2025-06-17T12:10:40.000Z - 1 year ago

Neuraxis announces new medical policy with two health insurers

Jun 17, 2025, 8:00 AM EDT - 1 year ago

NeurAxis Announces New Medical Policy Coverage with Two Health Insurers, Adding 700,000 Covered Lives

2025-06-16T13:15:09.000Z - 1 year ago

Craig-Hallum bullish on Neuraxis, initiates with a Buy

2025-06-16T11:30:07.000Z - 1 year ago

Neuraxis initiated with a Buy at Craig-Hallum

2025-06-10T12:30:42.000Z - 1 year ago

Neuraxis secures key academic society guidelines recommendation for FAP

May 29, 2025, 9:30 AM EDT - 1 year ago

NeurAxis Transcript: Lytham Partners Spring 2025 Investor Conference

2025-05-23T15:10:13.000Z - 1 year ago

Biotech Alert: Searches spiking for these stocks today

AKRO APVO CVM ETNB NLSP RLMD TIL

May 22, 2025, 1:03 PM EDT - 1 year ago

NeurAxis Announces Closing of $5.0 Million Registered Direct Offering

May 21, 2025, 7:00 AM EDT - 1 year ago

NeurAxis Announces $5.0 Million Registered Direct Offering

May 12, 2025, 9:00 AM EDT - 1 year ago

NeurAxis Earnings Call Transcript: Q1 2025

May 12, 2025, 9:00 AM EDT - 1 year ago

NeurAxis Earnings release: Q1 2025

May 12, 2025, 9:00 AM EDT - 1 year ago

NeurAxis Quarterly report: Q1 2025

May 12, 2025, 8:15 AM EDT - 1 year ago

NeurAxis Reports Strong First Quarter 2025 Financial Results Driven by a 39% Growth in Revenues

May 5, 2025, 9:00 AM EDT - 1 year ago

NeurAxis to Host First Quarter 2025 Results and Business Update Call on Monday, May 12, 2025

Apr 23, 2025, 5:00 PM EDT - 1 year ago

NeurAxis Transcript: Planet MicroCap Showcase: VEGAS 2025

Apr 14, 2025, 8:00 AM EDT - 1 year ago

NeurAxis Proxy statement: Proxy Filing

Apr 14, 2025, 8:00 AM EDT - 1 year ago

NeurAxis Proxy statement: Proxy Filing

Apr 4, 2025, 8:00 AM EDT - 1 year ago

NeurAxis Proxy statement: Proxy Filing

Mar 20, 2025, 9:00 AM EDT - 1 year ago

NeurAxis Earnings Call Transcript: Q4 2024

Mar 20, 2025, 9:00 AM EDT - 1 year ago

NeurAxis Earnings release: Q4 2024

Mar 20, 2025, 9:00 AM EDT - 1 year ago

NeurAxis Annual report: Q4 2024

Mar 20, 2025, 9:00 AM EDT - 1 year ago

NeurAxis Slides: Q4 2024

Mar 20, 2025, 8:15 AM EDT - 1 year ago

NeurAxis Reports Strong Fourth Quarter 2024 Financial Results Driven by a 43% Increase in Revenues

Mar 12, 2025, 9:00 AM EDT - 1 year ago

NeurAxis to Host Fourth Quarter and Full Year 2024 Results and Business Update Call on Thursday, March 20, 2025

Feb 5, 2025, 7:00 AM EST - 1 year ago

NeurAxis Registration statement: Registration Filing

Jan 21, 2025, 1:45 PM EST - 1 year ago

UPDATE - NeurAxis Announces New Medical Policy Coverage with a Prominent Insurer for Over Five Million Lives Across Multiple States

Jan 21, 2025, 9:00 AM EST - 1 year ago

NeurAxis Announces New Medical Policy Coverage with Molina Healthcare for Over Five Million Lives Across Multiple States

Jan 13, 2025, 2:30 PM EST - 1 year ago

NeurAxis Transcript: Lytham Partners 2025 Investor Healthcare Summit

Jan 13, 2025, 9:00 AM EST - 1 year ago

NeurAxis Inc. Issues Letter to Shareholders

Jan 6, 2025, 9:00 AM EST - 1 year ago

NeurAxis Inc. to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

Dec 13, 2024, 7:00 AM EST - 1 year ago

NeurAxis Registration statement: Registration Filing

Nov 12, 2024, 9:00 AM EST - 1 year ago

NeurAxis Earnings Call Transcript: Q3 2024

Nov 12, 2024, 9:00 AM EST - 1 year ago

NeurAxis Quarterly report: Q3 2024

Nov 12, 2024, 9:00 AM EST - 1 year ago

NeurAxis Earnings release: Q3 2024

Nov 12, 2024, 9:00 AM EST - 1 year ago

NeurAxis Slides: Q3 2024

Nov 12, 2024, 8:10 AM EST - 1 year ago

NeurAxis Reports Strong Third Quarter 2024 Financial Results Driven by a 40% Increase in Revenues

Oct 22, 2024, 9:00 AM EDT - 1 year ago

NeurAxis Announces New CPT® Category I Code for Percutaneous Electrical Nerve Field Stimulation

Oct 1, 2024, 12:30 PM EDT - 1 year ago

NeurAxis Transcript: Lytham Partners Fall 2024 Investor Conference

Sep 19, 2024, 9:00 AM EDT - 1 year ago

NeurAxis to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024

Aug 27, 2024, 9:00 AM EDT - 2 years ago

NeurAxis Announces Geisinger Health Plan Medical Policy Coverage for PENFS, Effective September 15 2024

Aug 13, 2024, 9:00 AM EDT - 2 years ago

NeurAxis Announces BCBS of Vermont Medical Policy Coverage for PENFS, effective October 1st 2024

Aug 9, 2024, 9:00 AM EDT - 2 years ago

NeurAxis Earnings Call Transcript: Q2 2024

Aug 9, 2024, 9:00 AM EDT - 2 years ago

NeurAxis Quarterly report: Q2 2024

Aug 9, 2024, 9:00 AM EDT - 2 years ago

NeurAxis Earnings release: Q2 2024

Aug 9, 2024, 8:00 AM EDT - 2 years ago

NeurAxis Reports Second Quarter 2024 Financial Results

Jul 1, 2024, 8:00 AM EDT - 2 years ago

NeurAxis Proxy statement: Proxy Filing

Jul 1, 2024, 8:00 AM EDT - 2 years ago

NeurAxis Proxy statement: Proxy Filing

Jun 21, 2024, 8:00 AM EDT - 2 years ago

NeurAxis Proxy statement: Proxy Filing

Jun 7, 2024, 9:00 AM EDT - 2 years ago

NeurAxis Announces New Submission to the FDA for the Expansion of its IB-Stim Label; Provides Compliance with NYSE Guidelines on Audit Disclosure

May 22, 2024, 9:00 AM EDT - 2 years ago

NeurAxis Earnings Call Transcript: Q1 2024

May 22, 2024, 9:00 AM EDT - 2 years ago

NeurAxis Quarterly report: Q1 2024

May 22, 2024, 9:00 AM EDT - 2 years ago

NeurAxis Earnings release: Q1 2024

May 22, 2024, 8:00 AM EDT - 2 years ago

NeurAxis Reports First Quarter 2024 Financial Results

May 21, 2024, 9:00 AM EDT - 2 years ago

NeurAxis to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024

May 15, 2024, 4:30 PM EDT - 2 years ago

NeurAxis to Host First Quarter 2024 Results and Business Update Call on Wednesday, May 22, 2024

Apr 23, 2024, 9:00 AM EDT - 2 years ago

NeurAxis Announces New Medical Policy Coverage in North Dakota

Apr 9, 2024, 4:05 PM EDT - 2 years ago

NeurAxis Reports Fourth Quarter and Fiscal Year 2023 Financial Results

Apr 9, 2024, 7:00 AM EDT - 2 years ago

NeurAxis Annual report: Q4 2023

Apr 9, 2024, 7:00 AM EDT - 2 years ago

NeurAxis Earnings release: Q4 2023

Apr 1, 2024, 4:15 PM EDT - 2 years ago

NeurAxis to Host Fourth Quarter and Full Year 2023 Results and Business Update Call on Tuesday, April 9, 2024

Mar 27, 2024, 9:00 AM EDT - 2 years ago

NeurAxis Announces IB-Stim Results from a Large, Pediatric, Multi-Center Registry

Mar 11, 2024, 9:00 AM EDT - 2 years ago

NeurAxis Announces Highmark BCBS Policy Coverage

Mar 4, 2024, 9:00 AM EST - 2 years ago

NeurAxis Announces Blue Cross and Blue Shield of Kansas City Policy Coverage

Feb 27, 2024, 11:00 AM EST - 2 years ago

NeurAxis to Present at Oppenheimer 34th Annual Healthcare MedTech & Services Conference

Jan 31, 2024, 9:00 AM EST - 2 years ago

NeurAxis Appoints Timothy Henrichs as Chief Financial Officer

Dec 20, 2023, 9:00 AM EST - 2 years ago

NeurAxis, Inc. Issues Letter to Shareholders from Brian Carrico, President and Chief Executive Officer

Nov 20, 2023, 5:30 PM EST - 2 years ago

NeurAxis Reports Third Quarter 2023 Financial Results

Nov 20, 2023, 8:00 AM EST - 2 years ago

NeurAxis Quarterly report: Q3 2023

Nov 20, 2023, 8:00 AM EST - 2 years ago

NeurAxis Earnings release: Q3 2023

Nov 15, 2023, 9:00 AM EST - 2 years ago

NeurAxis Announces CareFirst BCBS Policy Coverage

Nov 14, 2023, 9:00 AM EST - 2 years ago

NeurAxis Secures $3 Million Financing

Nov 8, 2023, 9:00 AM EST - 2 years ago

NeurAxis Signs Exclusive Option Agreement with University of Michigan for Innovative Gastrointestinal Device

Sep 21, 2023, 8:00 AM EDT - 2 years ago

NeurAxis Reports Second Quarter 2023 Financial Results

Sep 21, 2023, 8:00 AM EDT - 2 years ago

NeurAxis Quarterly report: Q2 2023

Sep 21, 2023, 8:00 AM EDT - 2 years ago

NeurAxis Earnings release: Q2 2023

Sep 13, 2023, 9:00 AM EDT - 3 years ago

NeurAxis to Present at the Gilmartin Group Emerging Growth Showcase

Sep 12, 2023, 9:00 AM EDT - 3 years ago

NeurAxis Announces Publication of Prospective Study Showing IB-Stim™ Improves Quality of Life of Adolescents with IBS

Aug 29, 2023, 9:00 AM EDT - 3 years ago

NeurAxis Highlights Pediatric Post-Concussion Clinical Study

Aug 24, 2023, 9:00 AM EDT - 3 years ago

NeurAxis Highlights Strength of its Board of Directors

Aug 22, 2023, 9:00 AM EDT - 3 years ago

NeurAxis Highlights Two Independent Studies Showing Benefits of IB-Stim in Adolescents Involving the Gut Microbiome

Aug 17, 2023, 9:02 AM EDT - 3 years ago

NeurAxis Announces Over $8 Million in IB-Stim™ Revenue

iAccess_Alpha Sep. 16 at 2:54 PM

$NRXS presentation replay is now available. Access the replay: https://www.webcaster5.com/Webcast/Page/3171/54417 #microcap #smallcap #investing

0 · Reply

MingChoo Sep. 16 at 2:52 PM

Thank you @ApolloAlerts. One of the best small-cap traders🔥 Made $20K today off his call. Give him a follow💯 Watching; $NAMI & $NRXS

0 · Reply

DylanGFM Sep. 16 at 2:48 PM

Check out medicine Nova $MNOV strong follow through on the daily $NRXS $MEDS

0 · Reply

Finnish_boy Sep. 16 at 2:22 PM

$NRXS This is how you play tiny float names.. lets go!💥🤑

0 · Reply

Finnish_boy Sep. 16 at 2:22 PM

$NRXS Two posts in a hour

0 · Reply

DylanGFM Sep. 16 at 2:20 PM

$NRXS Right. I meant as far as from this exact day on I wouldn't want to buy and hold from here, prob wait till it gets a bit lower for the next long term move iup

1 · Reply

CBAZZ03 Sep. 16 at 1:54 PM

$NRXS This will most definetly be a solid long term stock, think about public reaction once this company hits profitability

0 · Reply

DylanGFM Sep. 16 at 1:51 PM

0 · Reply

Finnish_boy Sep. 16 at 1:51 PM

$NRXS Cant buy this. Some issues with my broker😂it is what it is. Oh boy. And Cunha started pumping it.

1 · Reply

Stock_Catcher Sep. 16 at 1:49 PM

$NRXS new high

0 · Reply

DylanGFM Sep. 16 at 1:49 PM

$NRXS isn't looking too bad I made good money on it before and it surprisingly held a decent run up before New Year's and continued until May with a decent looking PR today

0 · Reply

CBAZZ03 Sep. 16 at 1:48 PM

$NRXS Holy smokas, flippin my flapjacks!🤩

0 · Reply

Finnish_boy Sep. 16 at 1:36 PM

$NRXS 19 million lives coverage. Earlier was 45 million. Great addition. Not sure will be there more this year. CEO comments have been confusing.

0 · Reply

marketk Sep. 16 at 1:31 PM

$NRXS lets go!

0 · Reply

STACKD0E Sep. 16 at 1:23 PM

$HLSQ $SNYR $NRXS 👁

0 · Reply

Finnish_boy Sep. 16 at 11:50 AM

$NRXS Profitable when run rate 15M-17M

0 · Reply

Finnish_boy Sep. 16 at 11:49 AM

$NRXS CEO told they are on the pace of 7-8M for full year. H1 was 3.55M. Lets use 8M. Then there will be 4.5M for H2. Q3: 2.0M and Q4: 2.5M Q3 earnings will be awful. Q4 starting point.

0 · Reply

Finnish_boy Sep. 15 at 1:18 PM

$NRXS CEO didnt tell "this year" or "next 3 months."

2 · Reply

Finnish_boy Sep. 15 at 1:09 PM

$NRXS "that research has allowed us to gain significant insurance policy coverage with significant more insurance policy coverage expected in the next 6 to 9 months." I will be back some day. I dont expect any new coverage this year. I am out.

0 · Reply

iAccess_Alpha Sep. 15 at 12:19 PM

$NRXS presents today. September 15, 2026 | 9:00 AM ET Watch live via Stocktwits or register here: https://www.webcaster5.com/Webcast/Page/3171/54417 #microcap #smallcap #investing

0 · Reply

iAccess_Alpha Sep. 14 at 1:26 PM

$NRXS presents tomorrow at iAccess Alpha's Virtual Best Ideas Fall Investment Conference. September 15, 2026 | 9:00 AM ET Register to watch live: https://www.webcaster5.com/Webcast/Page/3171/54417 #microcap #smallcap #investing

0 · Reply

cleverrox Sep. 14 at 12:21 PM

$NRXS Does Linzess Compete With NeurAxis IB-Stim? Microcap Opportunities Portfolio Stock NeurAxis Update https://microcapopportunities.substack.com/p/does-linzess-compete-with-neuraxis

0 · Reply

Market Cap	72.21M
Revenue (ttm)	3.57M
Net Income (ttm)	-7.80M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-218.49%
Debt to Equity Ratio	0.00

Volume	965,160
Avg Vol	79,830
Day's Range	N/A - N/A
Shares Out	12.56M
Stochastic %K	48%
Beta	1.47
Analysts	Strong Sell
Price Target	$13.00